All Posts

WASHINGTON—The Subcommittee on National Security, the Border, and Foreign Affairs held a hearing titled, “Wasteful Spending and Inefficiencies: Examining DoD Platform Performance and Costs.” Members discussed how stronger oversight and enforcement mechanisms, such as increased data analytic tools, are needed to steer the Department of Defense (DoD) ...

WASHINGTON—Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) delivered opening remarks at a full committee hearing titled “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.” In his opening statement, Chairman Comer detailed how the ...

WASHINGTON—Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued a report outlining how the three largest Pharmacy Benefit Managers (PBMs) —CVS Caremark, Express Scripts, and OptumRx—have monopolized the pharmaceutical marketplace by deploying deliberate, anticompetitive pricing tactics that are raising prescription drug prices, undermining community pharmacies, and harming patients across the United States. The House Oversight Committee will hold ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued the following statement after U.S. Secret Service Director Kimberly Cheatle announced her resignation: “The Oversight Committee’s hearing resulted in Director Cheatle’s resignation and there will be more accountability to come. The Secret Service has a no-fail mission yet it failed historically on Director Cheatle’s watch. At yesterday’s Oversight Committee hearing, ...

WASHINGTON—Subcommittee on Government Operations and the Federal Workforce Chairman Pete Sessions (R-Texas) today delivered opening remarks at a hearing titled “Oversight of the Council of the Inspectors General on Integrity and Efficiency.” Chairman Sessions discussed the Subcommittee’s goal to examine CIGIE’s legislative priorities, day-to-day ...

WASHINGTON—Today, the House Committee on Oversight and Accountability held a hearing titled “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.” At the hearing, Republicans and Democrats pressed Pharmacy Benefit Manager (PBM) chief executives on their role in rising prescription drug costs. ...